Increasing the Vaccine Potential of Live M. bovis BCG by Coadministration with Plasmid DNA Encoding a Tuberculosis Prototype Antigen

Vaccines
Nicolas BruffaertsKris Huygen

Abstract

The attenuated live M. bovis Bacille-Calmette-Guérin (BCG) is still the sole vaccine used against tuberculosis, but confers only variable efficacy against adult pulmonary tuberculosis (TB). Though no clear explanation for this limited efficacy has been given, different hypotheses have been advanced, such as the waning of memory T-cell responses, a reduced antigenic repertoire and the inability to induce effective CD8⁺ T-cell responses, which are known to be essential for latent tuberculosis control. In this study, a new BCG-based vaccination protocol was studied, in which BCG was formulated in combination with a plasmid DNA vaccine. As BCG is routinely administered to neonates, we have evaluated a more realistic approach of a simultaneous intradermal coadministration of BCG with pDNA encoding the prototype antigen, PPE44. Strongly increased T- and B-cell responses were observed with this protocol in C57BL/6 mice when compared to the administration of only BCG or in combination with an empty pDNA vector, as measured by Th1-type spleen cell cytokine secretion, specific IgG antibodies, as well as specific IFN-γ producing/cytolytic-CD8⁺ T-cells. Moreover, we observed a bystander activation induced by the coding plasmid, resulting i...Continue Reading

References

Aug 1, 1996·Nature Medicine·K HuygenJ B Ulmer
Feb 29, 2000·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·S L BaldwinJ B Ulmer
Feb 13, 2001·European Journal of Immunology·L A van PinxterenP Andersen
Jul 23, 2003·Infection and Immunity·B Villarreal-RamosC J Howard
May 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Marta RomanoKris Huygen
Apr 13, 2005·Journal of Medical Microbiology·Daniela BonanniCarlo Garzelli
Jun 21, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Marsha S RussellSubash Sad
Jul 10, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Angelika StoecklingerPeter Hammerl
Aug 31, 2007·FEMS Immunology and Medical Microbiology·Laura RindiCarlo Garzelli
Jan 29, 2008·BMC Infectious Diseases·Rosemary E WeirHazel M Dockrell
Jul 12, 2008·FEMS Microbiology Reviews·Nicole RitzNigel Curtis
Apr 22, 2009·PLoS Pathogens·Crystal Y ChenZheng W Chen
May 21, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Anthony A RyanJames A Triccas
Jul 10, 2009·Human Vaccines·Kenneth Von EschenW Ripley Ballou
Jan 28, 2010·European Journal of Immunology·Gianfranco Di GenovaFreda K Stevenson
Dec 29, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Christelle de BritoJacqueline Marvel
Jan 5, 2011·Immunological Reviews·Margaret A Liu
Aug 23, 2011·Expert Review of Vaccines·Mazal ElnekaveAvi-Hai Hovav
Jun 26, 2012·Nature Reviews. Immunology·Christophe J Desmet, Ken J Ishii
Sep 11, 2012·Expert Opinion on Biological Therapy·Marta Romano, Kris Huygen
Nov 7, 2013·Human Vaccines & Immunotherapeutics·Kun TanXionglin Fan

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent assay
ELISA
FCS
flow cytometry

Software Mentioned

GraphPad Prism

Related Concepts

Related Feeds

Antibody Repertoire Diversity

Antibody repertoire diversity and its role during natural infection is a prerequisite for molecular and structural elucidation of functionally protective immunity. Discover the latest insights into antibody diversity here.